Kristine Ball
Overview
Kristine Ball received an average of $1M in total compensation, including $311K in salary, at VYNE Therapeutics from 2017 to 2019.
Source: SEC filings on June 22, 2020 and May 10, 2019.
Related executives
We found seven more executives who work or worked at VYNE Therapeutics.
David Domzalski
VYNE Therapeutics
Chief Executive Officer
Mutya Harsch
VYNE Therapeutics
Chief Legal Officer
Iain Stuart
VYNE Therapeutics
Chief Scientific Officer
Steven Basta
VYNE Therapeutics
Chief Executive Officer
Andrew Saik
VYNE Therapeutics
Chief Financial Officer
Paul Kwon
VYNE Therapeutics
Chief Scientific Officer
Mary Spellman
VYNE Therapeutics